Arcturus Therapeutics Holdings Inc (ARCT) stock news · rev $82.0M
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
This ARCT news page leads with what Arcturus Therapeutics Holdings Inc filed — not a scraped headline mill.
No cached 8-K sentence for ARCT yet. We will not pad this page with generic market recap.
Latest reported ARCT revenue for 2025-12-31 was $82.0M. Net income was -$65.8M. Revenue was down 46.1% from 2024-12-31 to 2025-12-31. ARCT currently screens at market cap $369.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ARCT stock page; for the tape open the quote page.
ARCT stock news FAQ
What are ARCT's latest revenue and net income?
Latest cached Arcturus Therapeutics Holdings Inc (ARCT) revenue for Dec 31, 2025 was $82.0M. Net income was -$65.8M. Statements: https://lician.com/financials/arct
How did ARCT revenue change from the prior cached period?
Cached Arcturus Therapeutics Holdings Inc (ARCT) revenue was down 46.1% from $152.3M (Dec 31, 2024) to $82.0M (Dec 31, 2025). Statements: https://lician.com/financials/arct
What is ARCT's market cap?
Arcturus Therapeutics Holdings Inc (ARCT) market cap is $369.4M on the latest cached fundamentals snapshot.
What kind of company is ARCT?
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Where is ARCT stock news listed?
Cached stock news for Arcturus Therapeutics Holdings Inc (ARCT) is listed at https://lician.com/news/arct. Filings: https://lician.com/sec/arct
Not investment advice.